Lung cancer immunotherapy
Oncological studies of the lungs have shown that cancer cells have a very small amount of antigens that could be affected by immunotherapy. However, the results of the same experiments prove that immunotherapy for lung cancer can be an effective treatment for the disease.
Immunotherapy methods for treatment
There are two types of neoplasm in the lung:
- Small cell lung cancer (SCLC);
- Non-small cell lung cancer (NSCLC);
- Here you can add mesothelioma - a tumor of the pleura.
The greatest effectiveness in the use of immune drugs is observed in the treatment of NSCLC. But science does not stand still, and in medicine, work is underway to create methods of immunotherapy to combat SCLC and mesothelioma.
Several common types of immunotherapy are used in the treatment of lung neoplasms:
- Use of monoclonal antibodies;
- The use of inhibitors of substances that suppress immune reactions;
- Specially designed vaccines to activate B- and T-lymphocytes;
- Adaptive movement of T-lymphocytes, i.e. the patient's immune cells are modified at the gene level.
Scientists working in the field of activating the immune system face many difficulties, but despite this, immunotherapy still has broad prospects in the fight against cancer.
The author of the article: Bykov Evgeny Pavlovich | Oncologist, surgeon
Education: graduated from residency at the Russian Scientific Oncological Center. N. N. Blokhin "and received a diploma in the specialty" Oncologist"
